NEW YORK, Sept. 19, 2006 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) today announced that Alan G. Harris, MD, PhD, the company’s Chief Medical Officer, will chair the upcoming two-day Metabolic Syndrome Conference: Achieving Successful Drug Approval While Seizing Untapped Commercial Opportunities. The event will be held September 26-27 at the Radisson Hotel Boston in Boston, MA.
